Home
>
US Stocks
>
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc
SNDX

Syndax Pharmaceuticals Inc

$18.5712.48%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
18.58
Today Low/High
18.42 / 19
52 Week Low/High
$13.02 / $27.85
P/E ratio
-8.1506
Market Cap
$777.56M

Company Details

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor.
Organisation
Syndax Pharmaceuticals Inc
Headquaters
Waltham, Massachusetts, US
Employees
43
Industry
Health Technology
CEO
Briggs Morrison

Discover more

Frequently Asked Questions

What is Syndax Pharmaceuticals Inc share price today

Can Indians buy Syndax Pharmaceuticals Inc shares?

How can I buy Syndax Pharmaceuticals Inc shares from India?

Can Fractional shares of Syndax Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Syndax Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor